Microscopic Polyangiitis (MPA): Clinical Trials

1 trial for Microscopic Polyangiitis (MPA), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Not yet recruiting 1

Follow Microscopic Polyangiitis (MPA): new trials by email Literature Review of Microscopic Polyangiitis (MPA) trials Research Report on Microscopic Polyangiitis (MPA)

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of a Strategy Based on Clinico-biological Monitoring Versus Pre-emptive Rituximab Treatment in Cases of ANCA Reappearance in Granulomatosis With Polyangiitis and Microscopic Polyangiitis.
Rituximab - ANCA Associated Vasculitis (AAV), Polyangiitis (GPA)
Phase 4Not yet recruitingAssistance Publique - Hôpitaux de Paris702026-02-012026-03-05

Narrower conditions

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1)  ·  Granulomatosis with Polyangiitis (1)  ·  Microscopic Polyangiitis (1)  ·  Systemic Vasculitis (1)

Broader conditions

Autoimmune Diseases (1)  ·  Brain Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebral Small Vessel Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Immune System Diseases (1)  ·  Lung Diseases (1)  ·  Lung Diseases, Interstitial (1)  ·  Nervous System Diseases (1)  ·  Respiratory Tract Diseases (1)  ·  Skin Diseases (1)  ·  Skin Diseases, Vascular (1)  ·  Skin and Connective Tissue Diseases (1)  ·  Vascular Diseases (1)

Interventions

Rituximab (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)

Countries

France (1)

NIH funding

2025 (1)